Overview
Also known as:
Clinical phenotype terms— hover any for plain English:
FDA & Trial Timeline
4 eventsBlueprint Medicines Corporation
Universitaire Ziekenhuizen KU Leuven — PHASE4
University of Thessaly
Lille Catholic University
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Autosomal recessive spastic paraplegia type 21.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Autosomal recessive spastic paraplegia type 21 at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Autosomal recessive spastic paraplegia type 21.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Autosomal recessive spastic paraplegia type 21.
Community
No community posts yet. Be the first to share your experience with Autosomal recessive spastic paraplegia type 21.
Start the conversation →Latest news about Autosomal recessive spastic paraplegia type 21
Disease timeline:
New recruiting trial: Budesonide as a Treatment for Functional Dyspepsia
A new clinical trial is recruiting patients for Autosomal recessive spastic paraplegia type 21
New recruiting trial: Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
A new clinical trial is recruiting patients for Autosomal recessive spastic paraplegia type 21
New recruiting trial: Prevalence of Mast Cell Activation Syndrome in Patients With EDS With Digestive Disorders
A new clinical trial is recruiting patients for Autosomal recessive spastic paraplegia type 21
New recruiting trial: Role of Tryptase Levels in Patients With Stable Coronary Artery Disease.
A new clinical trial is recruiting patients for Autosomal recessive spastic paraplegia type 21
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.